Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia.
Talha BadarMark R LitzowRory Michael ShallisAnand Ashwin PatelAntoine N SalibaMadelyn BurkartJan Philipp BewersdorfMaximilian StahlGuilherme Sacchi De Camargo CorreiaGuru Subramanian Guru MurthyYasmin M AbazaAdam DuvallDanielle BradshawVamsi K KotaShira DinnerAaron D GoldbergNeil PalmisianoAref Al KaliEhab AtallahPublished in: Cancer (2022)
The current study highlights disparities between NHW and NHB patients with TP53-mutated AML. Efforts are warranted to eliminate treatment disparities in minority populations.